TrialAntimicrobial agents and chemotherapy2006

Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5).

Beda Joos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.